Welcome to LookChem.com Sign In|Join Free

CAS

  • or

23806-76-0

Post Buying Request

23806-76-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

23806-76-0 Usage

General Description

2-(benzyloxy)-3-methoxybenzoic acid, also known as 3-methoxy-2-(phenylmethoxy)benzoic acid, is a chemical compound with the molecular formula C16H14O4. It is a derivative of benzoic acid and is commonly used as an intermediate in the synthesis of pharmaceuticals and other organic compounds. The compound is a white to off-white crystalline solid, and its melting point is around 153-155°C. 2-(benzyloxy)-3-methoxybenzoic acid has been studied for its potential therapeutic properties, including anti-inflammatory and anticancer activities, although more research is needed to fully understand its pharmacological effects.

Check Digit Verification of cas no

The CAS Registry Mumber 23806-76-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,8,0 and 6 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 23806-76:
(7*2)+(6*3)+(5*8)+(4*0)+(3*6)+(2*7)+(1*6)=110
110 % 10 = 0
So 23806-76-0 is a valid CAS Registry Number.

23806-76-0Relevant articles and documents

COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CFTR

-

, (2017/08/01)

The present disclosure is directed to disclosed compounds that modulate, e.g., address underlying defects in cellular processing of CFTR activity.

7[4′-trifluoromethyl-biphenyl-2-carbonyl)amino]-quinoline-3-carboxylic acid amides, and method of inhibiting the secretion of apolipoprotein B

-

, (2008/06/13)

This invention relates to compounds of Formula I that inhibit the secretion of apolipoprotein B, to pharmaceutical compositions comprising the compounds, and to methods of treating and/or preventing atherosclerosis, obesity, diabetes, hyperlipidemia, hyperliproproteinemia, hypercholesterolemia, hypertriglyceridemia, hypoalphalipoproteinemia, pancreatitis, myocardial infarction, stroke, restenosis, or Syndrome X. This invention also relates to methods of reducing the secretion of apolipoprotein B and/or inhibiting microsomal triglyceride transfer protein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 23806-76-0